Regulus Therapeutics Inc.

CIK 1505512 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Regulus Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2025SCHEDULE 13G/A0001172661-25-003268
Aug 14, 2025SCHEDULE 13G/A0000902664-25-003697
Jul 7, 202515-12G0001104659-25-065915
Jul 1, 2025EFFECT9999999995-25-002107
Jul 1, 2025EFFECT9999999995-25-002106
Jul 1, 2025EFFECT9999999995-25-002112
Jul 1, 2025EFFECT9999999995-25-002105
Jul 1, 2025EFFECT9999999995-25-002118
Jul 1, 2025EFFECT9999999995-25-002119
Jul 1, 2025EFFECT9999999995-25-002104
Jul 1, 2025EFFECT9999999995-25-002108
Jun 27, 202540000950170-25-090992
Jun 27, 202540000950170-25-091026
Jun 27, 202540000950170-25-090986
Jun 27, 202540000950170-25-091015
Jun 27, 202540000950170-25-091003
Jun 27, 202540000950170-25-091036
Jun 27, 202540000950170-25-091032
Jun 27, 202540000950170-25-091006
Jun 27, 202540000950170-25-091008
Jun 27, 202540000950170-25-091020
Jun 27, 202540000950170-25-091035
Jun 27, 202540000950170-25-091019
Jun 25, 2025S-8 POS0001104659-25-062413
Jun 25, 2025S-8 POS0001104659-25-062415